发明申请
US20070275966A1 Oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators
失效
恶唑烷酮化合物及其作为代谢型谷氨酸受体增强剂的用途
- 专利标题： Oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators
- 专利标题（中）： 恶唑烷酮化合物及其作为代谢型谷氨酸受体增强剂的用途
-
申请号： US11634250申请日： 2006-12-06
-
公开(公告)号： US20070275966A1公开(公告)日： 2007-11-29
- 发明人: Abdelmalik Slassi , Methvin Isaac , Ian Egle , Fupeng Ma , Babu Joseph , Joshua Clayton , Krzysztof Swierczek
- 申请人： Abdelmalik Slassi , Methvin Isaac , Ian Egle , Fupeng Ma , Babu Joseph , Joshua Clayton , Krzysztof Swierczek
- 申请人地址： US UT Salt Lake City SE Sodertalje
- 专利权人： NPS PHARMACEUTICALS, INC.,AstraZeneca AB
- 当前专利权人： NPS PHARMACEUTICALS, INC.,AstraZeneca AB
- 当前专利权人地址： US UT Salt Lake City SE Sodertalje
- 主分类号： A61K31/421
- IPC分类号： A61K31/421 ; A61K31/497 ; C07D239/02 ; C07D413/02
摘要：
The present invention is directed to compounds of Formula I: Wherein R1, R2, Y, m and n are further defined in the description. The invention also relates to processes for the preparation of the compounds and to new intermediates employed in the preparation, pharmaceutical compositions containing the compounds, and to the use of the compounds in therapy.
公开/授权文献
信息查询
IPC分类:
